Healthconn

Healthconn FCF/Debt

The Free Cash Flow to Debt Ratio of Healthconn (6665.TWO) as of Nov 16, 2026 is 13.21 %. In the previous year, Free Cash Flow to Debt Ratio was 27.79 % — a change of -52.45% (lower).

FCF/Debt

13.21 %

YoY

-52.45%

Last updated:

Free Cash Flow to Debt Ratio of Healthconn is 2023 13.21 % . Free Cash Flow to Debt Ratio of Healthconn was 2022 27.79 % . It decreases by -52.45% lower compared to the previous year.

The Healthconn FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2017
265,145.92 TWD
Jan 1, 2018
1,086.22 TWD
Jan 1, 2019
143.39 TWD
Jan 1, 2020
44.66 TWD
Jan 1, 2021
2.06 TWD
Jan 1, 2022
27.79 TWD
Jan 1, 2023
13.21 TWD
The Healthconn FCF/Debt history
YEARFCF/DebtYoY
13.21 %-52.45%
27.79 %+1,248.14%
2.06 %-95.38%
44.66 %-68.86%
143.39 %-86.80%
1,086.22 %-99.59%
265,145.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Healthconn Stock analysis

What does Healthconn do? Healthconn Corp offers tailored lifestyle optimization solutions across nutrition, exercise, stress management, and sleep. The company provides precisely prevent medical integration services, including precise prevention, disease management, and health promotion. Molecular biology testing programs cover food safety and functional medical testing, while accurate diagnostic testing services encompass molecular and clinical microbiological testing. Healthconn also develops and operates medical health institutions and sells medical equipment. Its primary markets are Taiwan and mainland China, serving clients seeking integrated health and medical solutions. The firm’s revenue streams include precisely prevent medical integration services, molecular biology testing programs, accurate diagnostic testing services, and medical equipment sales. Clients are individuals and organizations focused on preventive healthcare, wellness, and diagnostic accuracy. The company targets the Taiwan and mainland China markets, delivering comprehensive health services through its medical health institutions and testing programs. Healthconn Corp’s business model combines lifestyle optimization with medical services, leveraging molecular testing and diagnostic capabilities. By integrating prevention, disease management, and health promotion, it caters to clients prioritizing proactive health strategies. The medical equipment sales segment complements its service offerings, enhancing accessibility to health solutions in Taiwan and mainland China. Healthconn is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Healthconn stock

Free Cash Flow to Debt Ratio of Healthconn is 13.21 % in 2023.

Free Cash Flow to Debt Ratio of Healthconn changed from 27.79 % to 13.21 %, representing a -52.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Healthconn since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Healthconn with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Healthconn

All Key Metrics — Healthconn